home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Hope for development of a leukemia vaccine

 
  December, 3 2001 9:29
your information resource in human molecular genetics
 
     
The BCR-ABL oncogene has for long been known to be a central player in the pathogenesis of chronic myeloid leukemia (CML). In the November 15th issue of Blood, researchers from UK have now demonstrated cell surface HLA-associated expression of a BCR-ABL oncogenic peptide. A cytotoxic T-lymphocyte response to the peptide was also shown to kill autologous CML cells, allowing Dr. Robert C. Rees of Nottingham Trent University and his colleagues to speculate that this observation may represent the first major step in the development of a vaccine against leukemia.

Contact :
Robert C. Rees
Department of Life Sciences
Nottingham Trent University
Nottingham NG11 8NS, UK
E-mail: robert.rees@ntu.ac.uk


Message posted by: Ulrike Sattler

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.